Alpha Medical Research   Report issue

Academic/Hospital Phase 2
Founded: Mississauga Canada

Organization Overview

First Clinical Trial
2009
NCT00867906
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

cat epidermis allergen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypersensitivity (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1